AME vs CPHI · P/E 30, rev $7.40B vs rev $4.1M
Ametek Inc (AME) versus China Pharma Holdings Inc (CPHI) — a side-by-side from cached financials, not a winner call.
Ametek Inc (AME) is a specialty industrial machinery company listed on US.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
Latest reported AME revenue for 2025-12-31 was $7.40B. Net income was $1.48B. Revenue was up 6.6% from 2024-12-31 to 2025-12-31. AME currently screens at market cap $42.11B and trailing P/E 29.9.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
AME currently screens at market cap $42.11B and trailing P/E 29.9. CPHI currently screens at market cap $29.0M.
Not investment advice. Open the AME and CPHI stock pages for the full models.
Not investment advice.